Table 4.
Unadjusted Mean (SD) | Adjusted Analysis for Old versus Young | |||||
---|---|---|---|---|---|---|
Age 60+ |
Age 18-59 |
Mean Difference (95% CI) |
t |
df |
P |
|
Physical Functioning | ||||||
Baseline | 46.64 (44.51) | 81.83 (33.56) | 6.84 (2.00 - 11.68) | 2.77 | 1079 | 0.01 |
6-month follow-up | 41.38 (41.55) | 65.02 (43.04) | 2.34 (-5.21 - 9.89) | 0.61 | 762 | 0.55 |
12-month follow-up | 43.83 (41.56) | 59.83 (44.52) | 8.01 (-0.46 - 16.48) | 1.86 | 669 | 0.07 |
Role Functioning | ||||||
Baseline | 10.63 (26.83) | 15.52 (29.73) | -2.03 (-6.63 - 2.57) | -0.86 | 1079 | 0.39 |
6-month follow-up | 27.26 (36.91) | 45.12 (39.68) | -0.07 (-7.08 - 6.95) | -0.02 | 762 | 0.99 |
12-month follow-up | 28.75 (39.03) | 51.20 (40.34) | -3.77 (-11.74 - 4.20) | -0.93 | 668 | 0.36 |
Bodily Pain | ||||||
Baseline | 59.20 (36.94) | 42.00 (31.89) | 1.28 (-4.03 - 6.58) | 0.47 | 1079 | 0.64 |
6-month follow-up | 49.22 (36.41) | 36.71 (31.96) | -0.18 (-6.22 - 5.87) | -0.06 | 762 | 0.96 |
12-month follow-up | 53.35 (37.11) | 36.39 (32.79) | 2.28 (-4.44 - 9.00) | 0.67 | 669 | 0.51 |
General Health | ||||||
Baseline | 20.11 (19.16) | 23.05 (18.49) | -0.40 (-3.37 - 2.58) | -0.26 | 1079 | 0.80 |
6-month follow-up | 28.35 (23.79) | 31.57 (20.72) | -1.09 (-5.13 - 2.95) | -0.53 | 762 | 0.60 |
12-month follow-up | 30.39 (25.93) | 34.83 (21.49) | -2.59 (-7.29 - 2.10) | -1.08 | 669 | 0.28 |
Social Functioning | ||||||
Baseline | 38.69 (34.23) | 46.52 (32.54) | 1.73 (-3.44 - 6.90) | 0.66 | 1078 | 0.52 |
6-month follow-up | 51.57 (38.12) | 68.86 (32.41) | -3.91 (-10.25 - 2.43) | -1.21 | 761 | 0.23 |
12-month follow-up | 57.02 (38.09) | 69.18 (32.49) | 1.72 (-5.21 - 8.65) | 0.49 | 668 | 0.63 |
Mental Health | ||||||
Baseline | 43.29 (23.20) | 35.66 (20.01) | 0.54 (-2.85 - 3.93) | 0.31 | 1079 | 0.76 |
6-month follow-up | 58.89 (24.12) | 57.52 (24.38) | -0.19 (-4.81 - 4.43) | -0.08 | 761 | 0.94 |
12-month follow-up | 61.21 (24.83) | 59.16 (25.00) | 2.52 (-2.58 - 7.61) | 0.97 | 668 | 0.34 |
Short-Form Health Survey (SF) was used to assess quality of life scales (range 0 to 100, high score indicated better functioning and more pain). Home Care trial used SF 20 items survey (SF-20) and others used SF 12 items survey (SF-12). ANCOVA models were adjusted for baseline scores, type of trials and intervention status. EUC indicates enhanced usual care; SD, standard deviation; CI, confidence interval. Number of participants varied across waves and outcomes (old adults - baseline n=440, 6-month n=287-288, 12-month n=253-254; young adults - baseline n=640-641, 6-month n=475-476, 12-month n=417).